Sartorius Stedim Biotech Virtual Annual Shareholders' Meeting on March 24, 2021
The health of shareholders and employees is a top priority for Sartorius Stedim Biotech. In view of the ongoing coronavirus pandemic, the Board of Directors has decided to hold the 2021 Annual General Meeting in camera, without the physical presence of shareholders, their proxies, or any other invitees in order to avoid any risk of infection (in accordance with Article 5 of Ordinance No. 2020-321 of March 25, 2020, adapting the rules for meetings and deliberations of the General Meetings as extended and amended by French Ordinance No. 2020-1497 of December 2, 2020). Shareholders and invitees were therefore requested not to physically travel to the venue of the Shareholders Meeting. They were asked to submit a prior vote at distance under the conditions set out in the documentation below.
Here you will find the information and documents that shareholders should have access to, regarding the virtual General Meeting of Shareholders held behind closed doors and via webcast, of Sartorius Stedim Biotech S.A. on March 24, 2021 at 2:00 p.m.
These documents are translated into English only for your convenience. The French originals, which have sole legal force, are available on the French website.
If you have any reason to assume that the documents provided on the website of Sartorius Stedim Biotech S.A. are incomplete, please contact us promptly at firstname.lastname@example.org.